LISA-101

Referenzen:

1. M. Orlowski, P.G. Richman and A. Meister, Biochemistry, 8, 1048 (1969) (Isolation and Identification of GGCT) 2. A.J. Oakley, T. Yamada, D. Liu, M. Coggan, A.G. Clark and P.G. Board, J. Biol. Chem., 283, 22031 (2008) (Isolation and Identification of GGCT) 3. P. Gromov, I. Gromova, E. Friis, V. Timmermans-Wielenga, F. Rank, R. Simon, G. Sauter and J.M.A. Moreira, J. Proteome. Res., 9, 3941 (2010) (Proteomic Profiling of Mammary Carcinomas) 4. K. Takemura, H. Kawachi, Y. Eishi, K. Kitagaki, M. Negi, M. Kobayashi, K. Uchida, J. Inoue, J. Inazawa, T. Kawano and P.G. Board, Human Pathol., 45, 331 (2014) (GGCT as a Diagnostic Marker in Esophageal Tumors) 5. R. Ran, Y. Liu, H. Gao, Q. Kuang, Q. Zhang, J. Tang, H. Fu, Z. Zhang and Q. He, J. Pharm. Sci., 104, 476 (2015) (siRNA for Treatment of Drug-Resistant Brest Cancer) 6. T. Yoshiya, H. Ii, S. Tsuda, S. Kageyama, T. Yoshiki and Y. Nishiuchi, Org. Biomol. Chem., 13, 3182 (2015) (Development of LISA-101)